Forty one pre-operative serum samples with paired tissue samples from HCC patients were assessed by the proposed Affimer-MAb CLIA assay and the dual-MAbs CLIA kit from DaRui, as well as by the IHC kit from LBP. Here, LBP is linked to hepatocellular carcinoma.